✦ LIBER ✦

Accelerated Hypofractionated Radiation vs. Standard Fractionated Radiation Concurrent with Cetuximab Chemotherapy in Locally Advanced Head and Neck Cancer (LAHNC)

✍ Scribed by S.L. Galper; H. Deshpande; M.G. Rose; J. Colasanto; R. Decker

Book ID: 108150325
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 50 KB
Volume: 75
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2009.07.992

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pretreatment hemoglobin levels are corre

Pretreatment hemoglobin levels are correlated with the effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer

✍ R.G Prosnitz; B Yao; C.L Farrell; R Clough; D.M Brizel 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 26 KB

Defining risk levels in locally advanced

Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

✍ Jacques Bernier; Jay S. Cooper; T. F. Pajak; M. van Glabbeke; J. Bourhis; Arlene 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 1 views

Phase 1 study to determine the maximum t

Phase 1 study to determine the maximum tolerated dose of radiation in standard fractionated and accelerated twice daily radiation schedules with concurrent chemotherapy for limited stage small cell lung cancer (CALGB 8837)

✍ N.C. Choi; J. Hemdon; J. Rosenman; R. Carey; C.T. Chung; S. Bemard; L. Leone; S. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Docetaxel, cisplatin, and fluorouracil i

Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II trial (S0216)

✍ David J. Adelstein; James Moon; Ehab Hanna; P. G. Shankar Giri; Glenn M. Mills; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

## Abstract ## Background In an effort to optimize nonoperative therapy in patients with locoregionally advanced head and neck squamous cell cancer, the Southwest Oncology Group conducted a phase II trial combining 3‐drug taxane‐containing induction chemotherapy with accelerated fractionation/conc